InvestorsHub Logo
Followers 13
Posts 1181
Boards Moderated 0
Alias Born 09/09/2010

Re: None

Thursday, 08/24/2017 9:49:10 AM

Thursday, August 24, 2017 9:49:10 AM

Post# of 13873
Just read this cam out just now
Immune Pharmaceuticals (IMNP -45%) enters into an agreement with institutional investors for the sale of $858K aggregate principal amount of convertible debentures. The conversion price will be $1.75 per common share but could drop as low as $1.00 under certain conditions.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.